NGM Biopharmaceuticals, Inc.

NGMNASDAQHealthcare

$1.54

$-0.02(-1.28%)

Market Cap$128532096

P/E Ratio—

52W High$4.69

52W Low$0.6002

Avg Volume970K

Open$1.56

Beta1.26

Employees Ownership Insider Trades

NGM Biopharmaceuticals, Inc. (NGM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NGM · as of Mar 11, 2024

Latest filing snapshot

138

-101-42.26%vs prior year

NGM Biopharmaceuticals, Inc. (NGM) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global

Total Employees

138

Change (1Y)

-101

Growth % (1Y)

-42.26%

Revenue / Employee

$32.0K

Net Income / Employee

$-1.03M

Market Cap

$129M

NGM Employee Count

2019 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-03-11	2023-12-31	138	-101	-42.26%
2023-02-28	2022-12-31	239	+14	+6.22%
2022-03-01	2021-12-31	225	+15	+7.14%
2021-03-15	2020-12-31	210	+24	+12.90%
2020-03-17	2019-12-31	186	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

PRTK

Paratek Pharmaceuticals, Inc.

268$128M #2

NGM

NGM Biopharmaceuticals, Inc.YOU

138$129M #3

KNTE

Kinnate Biopharma Inc.

84$125M #4

DBTX

Decibel Therapeutics, Inc.

68$123M #5

PRDS

Pardes Biosciences, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NGM peer comparison

About NGM employees

NGM Employees · Headcount

NGM Biopharmaceuticals, Inc. (NGM) employee data is sourced from the annual SEC 10-K filing. As of 2023, NGM Biopharmaceuticals, Inc. had 138 full-time employees globally. Full-time employees only. Global consolidated headcount.

NGM Biopharmaceuticals, Inc. employs 138 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $32,007, reflecting the company's operational efficiency.

NGM Biopharmaceuticals, Inc.'s workforce decreased by 101 (42.26%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

NGM Biopharmaceuticals, Inc.'s revenue per employee of $32,007 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NGM Employees · 5 questions

As of the latest SEC 10-K filing (2023), NGM Biopharmaceuticals, Inc. had 138 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

NGM Biopharmaceuticals, Inc. employee counthow many employees does NGM Biopharmaceuticals, Inc. haveNGM total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-03-11